1. Rationale and design of the EPCHF trial: the early palliative care in heart failure trial (EPCHF)

   • Marc Ulrich Becher
   • Mahmoud Balata
   • Georg Nickenig

   Trial Design Open access 09 July 2021 Pages: 359 - 367

   

2. Serum potassium dynamics during acute heart failure hospitalization

   • Pedro Caravaca Perez
   • José R. González-Juanatey
   • Juan F. Delgado

   Original Paper 17 October 2020 Pages: 368 - 379

   

3. Serum sodium and eplerenone use in patients with a myocardial infarction and left ventricular dysfunction or heart failure: insights from the EPHESUS trial

   • Pieter Martens
   • João Pedro Ferreira
   • Patrick Rossignol

   Original Paper 23 April 2021 Pages: 380 - 392

   

4. Exercise hemodynamics in heart failure patients with preserved and mid-range ejection fraction: key role of the right heart

   • Andreas J. Rieth
   • Manuel J. Richter
   • Christian W. Hamm

   Original Paper 10 June 2021 Pages: 393 - 405

   

5. Establishing a cardiac training group for patients with heart failure: the “HIP-in-Würzburg” study

   • Gülmisal Güder
   • Joana Wilkesmann
   • Stefan Störk

   Original Paper Open access 22 June 2021 Pages: 406 - 415

   

6. Diastolic dysfunction in individuals with and without heart failure with preserved ejection fraction

   • Jan-Per Wenzel
   • Ramona Bei der Kellen
   • Julius Nikorowitsch

   Original Paper Open access 16 July 2021 Pages: 416 - 427

   

7. Influence of receptor selectivity on benefits from SGLT2 inhibitors in patients with heart failure: a systematic review and head-to-head comparative efficacy network meta-analysis

   • Tobias Täger
   • Lutz Frankenstein
   • Hanna Fröhlich

   Original Paper Open access 08 September 2021 Pages: 428 - 439

   

8. Growth differentiation factor 15 predicts poor prognosis in patients with heart failure and reduced ejection fraction and anemia: results from RED-HF

   • Thor Ueland
   • Lars Gullestad
   • Pål Aukrust

   Original Paper Open access 05 October 2021 Pages: 440 - 450

   

9. Weight changes in heart failure with preserved ejection fraction: findings from TOPCAT

   • João Pedro Ferreira
   • Patrick Rossignol
   • Faiez Zannad

   Original Paper 10 November 2021 Pages: 451 - 459

   

10. The burden of cardiovascular outcomes in heart failure patients with new-onset, prevalent, and without type 2 diabetes

    • Bochra Zareini
    • Paul Blanche
    • Morten Lamberts

    Original Paper 24 January 2022 Pages: 460 - 468

    

11. SGLT2 inhibitor therapy and pulmonary artery pressure in patients with chronic heart failure—further evidence for improved hemodynamics by continuous pressure monitoring

    • Klara Kirschbaum
    • Mariuca Vasa-Nicotera
    • Sebastian Cremer

    Letter to the Editors Open access 24 October 2021 Pages: 469 - 472

    

12. Correction to: Predicting survival in heart failure: a risk score based on machine-learning and change point algorithm

    • Wonse Kim
    • Jin Joo Park
    • Dong-Ju Choi

    Correction 29 November 2021 Pages: 473 - 473